Skip to main content
Caplight Logo









CyGenica

CyGenica

Private
IrelandHealthcare & Life Scienceshttps://cygenica.com/

Last Round

Seed

Jun 8, 2021

Total Funding Raised

$3.56M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CyGenica is a biotechnology company that provides a non-viral, non-toxic platform for safe and targeted molecular delivery for intracellular therapeutic development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

intracellular drug deliverydrug delivery platformprotein nanoneedlenon-viral deliverynon-viral vectorlarge molecule deliveryendosomal escapegene therapy deliveryRNA deliverydrug delivery vehicleprotein deliverygene editing deliveryoncology therapeuticsrare genetic diseasesbiopharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CyGenica Comparables

Compare CyGenica with similar companies based on industry and business-model similarity.

CyGenica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoSyrinx
86%
Sapreme Technologies BV
83%
iDEL Therapeutics
82%

CyGenica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 8, 2021

Key People

Founding team and executive leadership

Nusrat Sanghamitra

Founder, CEO

Founding Team

CyGenica Investors

Notable investors and investment history

CyGenica investors
InvestorRounds
Voyagers.ioSeed
Biotechnology Industry Research Assistance CouncilGrant
SOSVConvertible Debt, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors increased 2154% MoM, reaching 1.6K.

  • Apr 18, 2026

    Monthly visitors increased 355% MoM.

CyGenica Filings

Explore SEC and related filing metadata, where available.

CyGenica filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CyGenica's valuation, stock price, and market status.

Is CyGenica a public or private company?

CyGenica is a private company.

What is the current stock price of CyGenica?

CyGenica is a private company with no public stock price. No recent secondary market data is available.

How much is CyGenica worth (valuation)?

Valuation information for CyGenica is not publicly available.

Can I buy CyGenica stock?

CyGenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CyGenica's last funding round?

CyGenica's most recent funding round was Seed on June 8, 2021.

Who are the main investors in CyGenica?

Key investors in CyGenica include SOSV.

Will CyGenica IPO soon?

No public IPO plans have been announced for CyGenica.

How can I track CyGenica secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CyGenica's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIreland
Employee Range14
Year Founded2017
Last FundingJun 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?